SAN FRANCISCO, July 05, 2022 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the…
- Tumor shrinking observed in substantially all patients who were evaluable at 16 weeks - - Favorable safety results observed:…
Lindsay Androski, JD, MBA brings significant experience growing biotech companies through her roles as an executive at Roivant Social Ventures…
SEATTLE, July 05, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development…
Awakn Provides Business Update on Progressing its Lead Program from Phase II b to Phase IIIToronto, Ontario--(Newsfile Corp. - July…
DALLAS--(BUSINESS WIRE)--#Healthcare--The American Medical Association (AMA) has issued two unique Category III Current Procedural Terminology (CPT®) codes for Quantitative Magnetic…
New Study Evaluates Masimo SafetyNet in Helping Patients Recover at Home IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings…
Bringing More Than 20 Years of Experience to Sonendo, Lindberg Will Focus on Accelerating Sales Growth LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo,…
Vancouver, British Columbia--(Newsfile Corp. - July 5, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…
STOCKHOLM, SWEDEN / ACCESSWIRE / July 5, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical…